financetom
Business
financetom
/
Business
/
Primo Brands Poised for Long-Term Growth Despite Short-Term Headwinds, RBC Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Primo Brands Poised for Long-Term Growth Despite Short-Term Headwinds, RBC Says
Mar 11, 2026 5:27 AM

12:02 PM EST, 02/24/2026 (MT Newswires) -- Primo Brands ( PRMB ) is facing some caution heading into Q4 earnings, with analysts at RBC Capital Markets slightly below the sell-side consensus while in line buy-side expectations, according to a note Tuesday.

The caution stems from a smaller, less tenured user base caused by customer churn following recent service disruptions, despite positive retail scanner data, the firm said.

The company's delivery business continues to face material headwinds, though conditions are improving, and there may be additional headwinds for the direct delivery business in Q1 due to winter storm disruptions, RBC said.

The RBC analysts said they have conviction in the company's recovery narrative, despite a Q4 top-line expected to decline 7% sequentially due to a smaller, lower-spending customer base and a guidance cut, which is common when a new CEO sets expectations during a company turnaround.

Primo Brands ( PRMB ) is scheduled to report Q4 and full-year financial results on Thursday.

RBC maintained its outperform rating on the stock and a $26 price target.

Price: 19.30, Change: +0.29, Percent Change: +1.50

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Blackstone, Bain to bid for Mitsubishi pharma unit in up to $3.5 bln deal, sources say
Blackstone, Bain to bid for Mitsubishi pharma unit in up to $3.5 bln deal, sources say
Dec 13, 2024
HONG KONG, Dec 13 (Reuters) - Global private equity firms Blackstone and Bain Capital are among final bidders for Mitsubishi Tanabe Pharma, a unit of Japan's Mitsubishi Chemical Group ( MTLHF ), in a deal that could value it at between $3 billion and $3.5 billion, three sources said. Mitsubishi Chemical ( MTLHF ) has hired Goldman Sachs ( GS...
VEON's Q3 Earnings Fall, Revenue Increases
VEON's Q3 Earnings Fall, Revenue Increases
Dec 13, 2024
05:34 AM EST, 12/13/2024 (MT Newswires) -- VEON (VEON) reported Q3 earnings Friday of $0.12 per diluted share, down from $0.26 a year earlier. Revenue for the quarter ended Sept. 30 was $1.04 billion, up from $945 million a year earlier. A single analyst polled by FactSet expected $1.01 billion. Shares of the company fell more than 5% in recent...
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Dec 13, 2024
Dec 13 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1030 GMT on Friday: ** Swiss technology firm SoftwareOne Holding confirmed that it is in advanced discussions to acquire Norwegian rival Crayon Group Holding ( CRAYF ) for a consideration of cash and shares. ** Australia's Insignia Financial ( IOOFF ) said it has received a...
UnitedHealth Group CEO Andrew Witty says healthcare system is flawed
UnitedHealth Group CEO Andrew Witty says healthcare system is flawed
Dec 13, 2024
(Reuters) -UnitedHealth Group ( UNH ) CEO Andrew Witty called the U.S. healthcare system flawed and said the company, along with employers and governments, needs to work on the way it explains insurance coverage decisions. In a New York Times opinion piece on Friday, Witty mourned the killing of Brian Thompson, the CEO of UnitedHealth's ( UNH ) health insurance...
Copyright 2023-2026 - www.financetom.com All Rights Reserved